NGVT 8-K 2026-11-04
Ingevity Corp (NGVT) 8-K dated 2026-11-04 — accession 0001653477-26-000061.
Ingevity Corp (NGVT) is a specialty chemicals company listed on NYSE.
NGVT revenue $45M, +18% YoY
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported NGVT revenue for 2025-12-31 was $1.17B. Net income was -$167.1M. Revenue was down 17.0% from 2024-12-31 to 2025-12-31. NGVT currently screens at market cap $2.52B.
Not investment advice. The NGVT SEC hub lists recent forms. The stock page is the research view.
- Revenue
- $45M
- YoY
- +18%
- Diluted EPS
- $1.31
- Guidance
- full year adjusted EBITDA outlook to a range of $385 million to $395 million, maintaining the midpoint of the prior range
Why it matters
- full year adjusted EBITDA outlook to a range of $385 million to $395 million, maintaining the midpoint of the prior range
- Third quarter results reflect disciplined execution across the portfolio amid a mixed global demand environment,…